![]() ![]() ![]() “The new genetic research paradigm built by Kári Stefánsson is helping Amgen to answer basic questions about the biological roots of disease,” said Sean Harper, executive vice president for Research and Development at Amgen. Amgen is working closely with deCODE to incorporate its research into Amgen’s drug discovery programs in an effort to enhance and accelerate target discovery, validation and prioritization. Potential new medicines with biological targets validated by human genetics are more likely to succeed in clinical trials and be approved for use in patients. “deCODE’s work has inspired similar large-scale studies in other countries, including the UK Biobank and the United States’ All of Us initiative.”ĭeCODE’s research is also providing a stronger, more innovative foundation for drug discovery. The society also noted that deCODE’s ambitious approach to genetics is being emulated today by major research organizations. Their research has also helped explain key biological processes, such as recombination, de novo mutations, and parent-of-origin effects.” “deCODE has identified variants associated with many phenotypes, such as type 2 diabetes, prostate cancer, heart attack, and schizophrenia. In announcing Kári’s selection, the society observed that his discoveries have encompassed both specific genes and broad scientific principles. Kári is the CEO of deCODE, the Iceland-based subsidiary of Amgen. The prize was presented to Kári on October 18 at the ASHG Annual Meeting in Orlando, Florida. Recipients are selected based on their far-reaching contributions to the field, combined with a record of research productivity sustained over many years. For his vision in founding deCODE and long-term success as the company’s scientific leader, Kári Stefánsson has been honored with the 2017 William Allan Award.Įstablished in memory of a leading pioneer in human genetics research, the William Allan Award is the top prize bestowed by the American Society for Human Genetics (ASHG). The American Society for Human Genetics bestows its top prize, the William Allan Award, on the founder of deCODE Genetics, an Amgen subsidiary.įor more than 20 years, deCODE Genetics has been a prolific source of major discoveries into the ways that variations in the human genome impact our risk for disease. Clinical Trial Diversity and RepresentationĬlinical Trial Transparency, Data Sharing and Disclosure PracticesĪdverse Event and Product Complaint ReportingĮnvironmental, Social & Governance Report 2022Įnvironment, Social and Governance StrategyĬommunity Investment and Amgen Foundation ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |